Company intelligence / Profile preview

Ben Venue Laboratories

Bedford, Ohio, United Statesbedfordohio.org ↗

Ownership: Private
Employees: ~1100
Development stage: Commercial

Overview

Ben Venue Laboratories was a leading U.S. contract manufacturer and supplier of generic sterile injectable drugs, primarily for acute-care and oncology. Due to sustained manufacturing and quality issues, the company ceased operations in 2014. Its operations and assets, including the Bedford Laboratories generics business and the manufacturing facility, were sold to Hikma Pharmaceuticals. No current pipeline or clinical development activity exists under the Ben Venue name since its closure.[1][2][3][5][6][7]

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Ben Venue Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ben Venue Laboratories.

Explore the full profile